Linike Medical Group Ltd.
LNMG
$0.0061
$0.00011.67%
OTC PK
| 07/31/2014 | 04/30/2014 | 01/31/2014 | 10/31/2013 | 07/31/2013 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -65.84% | -37.04% | -- | -- | -- |
| Depreciation & Amortization | 34,933.33% | 41,960.00% | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.55% | 55.46% | -- | -- | -- |
| Operating Income | -10.55% | -55.46% | -- | -- | -- |
| Income Before Tax | -10.91% | -57.70% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -10.91% | -57.70% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -10.91% | -57.70% | -- | -- | -- |
| EBIT | -10.55% | -55.46% | -- | -- | -- |
| EBITDA | -117.82% | -345.39% | -- | -- | -- |
| EPS Basic | 79.26% | 72.73% | -- | -- | -- |
| Normalized Basic EPS | 79.27% | 72.77% | -- | -- | -- |
| EPS Diluted | 79.26% | 72.73% | -- | -- | -- |
| Normalized Diluted EPS | 79.27% | 72.77% | -- | -- | -- |
| Average Basic Shares Outstanding | 243.19% | 345.48% | -- | -- | -- |
| Average Diluted Shares Outstanding | 243.19% | 345.48% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |